Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
Discovery
Custom biospecimen sourcing
Target identification
Target expression profiling
Preclinical
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
Featured
Xenium for cells
Trials
Biomarker analysis
TLS detection & evaluation
Platforms
Spatial Biology
Xenium: Single-cell spatial transcriptomics
GeoMx: Digital spatial profiling
Visium HD: Whole-Transcriptome Spatial Biology
IHC/IF: Digital pathology
Multi-Omics
Single-cell RNA Seq
Proteomics
Flow cytometry
Bioinformatics
10x Genomics Datasets
Bulk RNA-seq & GeoMx DSP Datasets
mIF & IHC Image Analysis
About
About Explicyte
Science
Commitments
News
Careers
Contact us
Toggle menu
Contact us
CRO Services
Explicyte Immuno-Oncology
>
CRO Services
View Details
Tumor antigen-specific T cell killing
View Details
Immune cell-mediated tumor killing assays
View Details
TLS Detection & Scoring for Cancer Immunotherapy
View Details
Syngeneic Tumor Models for the In Vivo Assessment Cancer Immunotherapies
View Details
TLS Detection and Scoring by Digital Pathology
View Details
In Vivo Models Of CTLA-4 Blockade
View Details
In Vivo Models Of PD-1/PD-L1 Axis Blockade
View Details
In Vivo immunization tumor models
View Details
Biomarker Discovery & Testing for Immuno-Oncology
View Details
Immune Response Profiling for Cancer Immunotherapies – Preclinical CRO Services
View Details
Flow cytometry
View Details
Proteomics
Previous page
1
2
3
4
5
Next page
WordPress Lightbox
